Cited by — Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease.
No admitted local citation edges point to this work yet.
